Centers for Research on Neglected Infectious Diseases
Agency
National Institutes of Health
Posted
Oct 6, 2026
Due Date
Jun 15, 2027
Description
<p>The National Institute of Allergy and Infectious Diseases (NIAID) seeks to advance its mission by supporting multidisciplinary research through the Centers for Research on Neglected Infectious Diseases (CReNIDs). Neglected infectious diseases (NIDs) comprise a diverse and understudied group of communicable viral, bacterial, parasitic, and fungal infections that cause substantial morbidity, mortality, and long-term health consequences worldwide. This new research program will emphasize the epidemiology, pathogenesis, diagnosis, treatment, and prevention of communicable parasitic NIDs in endemic regions and build sustainable in-country research capacity and expertise. The overarching goal is to protect and improve the health of the American people by strengthening US and global multidisciplinary research and training on NIDs to enable early identification, containment, and mitigation of infectious diseases at their sources, thereby reducing the risk of their spread to and within the United States. Grant authorities that allow NIAID to forecast this opportunity are as follows: Sections 301 and 405 of the Public Health Service Act as amended (42 USC 241 and 284) and under Federal Regulations 42 CFR Part 52 and 2 CFR Part 200.</p>
AI Summary
Estimated Funding: 4,200,000 | Agency: National Institutes of Health
Details
- Notice ID
- 364027
- Solicitation Number
- RFA-AI-28-020
- Classification Code
- D
Want to track opportunities like this?
Sign up for Kontratar to get AI-powered opportunity matching, ranking, and alerts.
Get Started FreeRelated opportunities
- Leveraging NAMs to understand disease triggers, discover early biomarkers and develop new classes of therapeutic strategies for Type 1 Diabetes (U01 Clinical Trial Not Allowed)
National Institutes of Health
- Systems Biology of Infection and Inflammation in Chronic Diseases (U19 Clinical Trial Not Allowed)
National Institutes of Health
- Research on System Support and Tools for Provider Training and Quality Monitoring for Suicide Preventive Care (RP1- Clinical Trial Optional)
National Institutes of Health
- Genomic and Biologic Therapies for ADRD (U01 Clinical Trial Optional)
National Institutes of Health
- The NIDDK Disorders of Gastrointestinal Interoception Consortium (DGIC) - Clinical Research Centers (U01 Clinical Trial Not Allowed)
National Institutes of Health
- The NIDDK Disorders of Gastrointestinal Interoception Consortium (DGIC) Scientific Data Research Center (U24 Clinical Trial Not Allowed)
National Institutes of Health
- Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)
National Institutes of Health
- George M. O’Brien Urology Cooperative Research Centers Program (U54 Clinical Trial Optional)
National Institutes of Health